• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Anemia, Hemolytic, Autoimmune

Anemia, Hemolytic, Autoimmune - 3 Studies Found

Completed : Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders
:
  • Bullous Pemphigoid (BP)
  • Cold Agglutinin Disease
  • Warm : 2015-07-07
    :
    • Drug: TNT009
    • Other: Placebo

Completed : The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
:
  • Pemphigus
  • Auto-immune Thrombocytopenic Purpura
  • : 2009-07-16
    : Drug: Rituximab (MABTHERA® or RITUXAN®). patients can be included in the study whatever the do
Active, not recruiting : Sirolimus for Autoimmune Disease of Blood Cells
:
  • Autoimmune Pancytopenia
  • Autoimmune Lymphoproliferative Syndrome (ALPS)
  • Orthopedics Health
    Orthopedics Health WebHealth Network Media
    • WebHealthNetwork
    • DiabetesHealthMatters
    • HeartandStrokeHealth
    • WomensHealthCareCommunity
    • AsthmaHealthCenter
    • CancerHealthCenter
    • MentalHealthHelpCenter
    • Skincarehealthcenter
    • DigestiveTractHealth
    • VaccineHealthCenter
    • PainHealthCenter
    • FightingAddictionCenter
    • ObesityHealthMatters
    • SeniorHealthcareMatters
    • BrainAndNerveCenter
    • PediatricsHealthCenter
    • RareDiseasesHealthCenter
    • Wealth Mason
    • Home Owners Circle
    • EasyInsuranceFinder
    • EduJumpStart
    • SaleSpider
    • ScoopCafe
    • SaleSpiderMedia
    • Viewpoint.World
    • TravelerBooked
    • TechNewsBytes
    • Contact Us
    • Advertising Privacy Policy

    This site uses cookies for analytics and advertising. No personal information is collected.

    © Orthopedics Health .

    We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.